HassanBAlkhateebMD

PubMed

• Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.
  Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna
  American Journal of Hematology. 2024-12-13
• 1 citations
  A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete Remission.
  Zaid Abdel Rahman, Tamer Othman, Rima M Saliba, Yenny Alejandra Moreno Vanegas, Razan Mohty
  Transplantation and Cellular Therapy. 2024-12-01
• Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasms.
  Mahmoud Yacout, Bahga Katamesh, Yazan Jabban, Rong He, David Viswanatha
  Leukemia. 2024-12-01

Journal Articles

• Phase 1b Study of IGF-Methotrexate Conjugate in the Treatment of High-Grade Myelodysplastic Syndromes  
  Hassan Alkhateeb, MD, Anticancer Research

Abstracts/Posters

• Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Ly...
  Hassan B. Alkhateeb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma
  Hassan B. Alkhateeb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Survival Outcomes Following Allogeneic Stem Cell Transplantation for Inherited Bone Marrow Failure and Myeloid Germline Predisposition Syndromes
  Hassan B. Alkhateeb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial
  Hassan B. Alkhateeb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Characteristics and Outcomes of Therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation
  Hassan B. Alkhateeb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• A Phase II of Combination Daunorubicin and Cytarabine (Ara-c) and Nilotinib (TAsigna) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018